Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
deals
7
×
detroit blog main
detroit top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
7
×
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
national
cancer
cancer immunotherapy
europe blog main
europe top stories
fda
pfizer
alzheimer's disease
amag pharmaceuticals
astrazeneca
gilead sciences
investing
What
bio
roundup
develop
sciences
acquisitions
amid
bombast
buy
cancer
caught
ceo
coronavirus
daniel
debate
discussion
efforts
gilead
life
meso’s
miss
o’day
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
years
admits
ago
alliance
announced
bails
big
biggest
biotechs
brand
bridgebio
Language
unset
7
×
Current search:
deals
×
unset
×
" texas blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In